By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Oculis Publishes 2025 Consolidated Financial Statements
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Oculis Publishes 2025 Consolidated Financial Statements
Oculis Publishes 2025 Consolidated Financial Statements
Health

Oculis Publishes 2025 Consolidated Financial Statements

GlobeNews Wire
Last updated: 05/03/2026 2:38 PM
GlobeNews Wire
Published: 05/03/2026
Share
SHARE

ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) — Following the Company‘s press release published on March 3, the audited consolidated financial statements for the financial year 2025 and the MD&A, which have now been filed with the SEC on form 20-F, are attached.

Attachments

  • Oculis 2025 Consolidated IFRS Financial Statements
  • Oculis 2025 MD&A
  • Oculis ESEF reporting
DIFC’s H1 2025 results fuel Dubai’s economic vision (D33) and demonstrate global leadership in financial services and innovation
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
NTT DATA Receives Frost & Sullivan’s 2025 Asia-Pacific Competitive Strategy Leadership Recognition for Excellence in Generative AI Solutions
New Tokens Average at 2,341%, TradFi Futures Volume Climbs 55%: MEXC April Report
Anavar for Women: Exploring the Rise of Anvarol Performance Supplement Among Female Bodybuilders and Athletes From CrazyBulk
TAGGED:2025CH1242303498consolidatedfinancialIceland:OCSIceland:OCS.ICNasdaq:OCSnewsoculispublishesstatements
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntingtons Disease and Establishes Clinical Advisory Board
Health

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntingtons Disease and Establishes Clinical Advisory Board

GlobeNews Wire
GlobeNews Wire
16/02/2026
IBA Launches myQAMatriXXAiR to Advance PatientSpecific QA in Particle Therapy
Ubiquity Receives Frost & Sullivan’s 2025 North American Transformational Innovation Leadership Award for Excellence in Customer Experience Management
INVITATION FOR EXPRESSION OF INTEREST – For Divestiture of ‘Canwill Holdings (Pvt) Ltd’
Processa Pharmaceuticals Provides Portfolio and Business Update
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?